|
|
The kidney as a reservoir for HIV-1 after renal transplantation.
Guillaume Canaud
,
Nathalie Dejucq-Rainsford
,
Véronique Avettand-Fenoël
,
Jean-Paul Viard
,
Dany Anglicheau
et al.
Journal articles
hal-01121764v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Activation of the PI3K/AKT/mTOR Pathway in Cajal–Retzius Cells Leads to Their Survival and Increases Susceptibility to Kainate-Induced Seizures
Nasim Ramezanidoraki
,
Driss El Ouardi
,
Margaux Le
,
Stéphanie Moriceau
,
Mahboubeh Ahmadi
et al.
Journal articles
hal-04083303v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy.
Olivia Boyer
,
Fabien Nevo
,
Emmanuelle Plaisier
,
Benoît Funalot
,
Olivier Gribouval
et al.
Journal articles
inserm-00919173v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot
,
Thomas Blanc
,
Smail Hadj Rabia
,
Laureline Berteloot
,
Sophia Ladraa
et al.
Journal articles
hal-01877949v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients.
Lena Berchtold
,
Eric Letouzé
,
Mariam Priya Alexander
,
Guillaume Canaud
,
Anne-Els van De Logt
et al.
Journal articles
hal-02935575v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases
Simon C. Johnson
,
Frank Martinez
,
Alessandro Bitto
,
Brenda Gonzalez
,
Cagdas Tazaerslan
et al.
Journal articles
hal-03486913v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|